Literature DB >> 33670895

Novel lncRNAs Co-Expression Networks Identifies LINC00504 with Oncogenic Role in Luminal A Breast Cancer Cells.

Carolina Mathias1, Clarice S Groeneveld2,3, Sheyla Trefflich4, Erika P Zambalde1, Rubens S Lima5, Cícero A Urban5, Karin B Prado1, Enilze M S F Ribeiro1, Mauro A A Castro4, Daniela F Gradia1, Jaqueline C de Oliveira1.   

Abstract

Long non-coding RNAs (lncRNAs) are functional transcripts with more than 200 nucleotides. These molecules exhibit great regulatory capacity and may act at different levels of gene expression regulation. Despite this regulatory versatility, the biology of these molecules is still poorly understood. Computational approaches are being increasingly used to elucidate biological mechanisms in which these lncRNAs may be involved. Co-expression networks can serve as great allies in elucidating the possible regulatory contexts in which these molecules are involved. Herein, we propose the use of the pipeline deposited in the RTN package to build lncRNAs co-expression networks using TCGA breast cancer (BC) cohort data. Worldwide, BC is the most common cancer in women and has great molecular heterogeneity. We identified an enriched co-expression network for the validation of relevant cell processes in the context of BC, including LINC00504. This lncRNA has increased expression in luminal subtype A samples, and is associated with prognosis in basal-like subtype. Silencing this lncRNA in luminal A cell lines resulted in decreased cell viability and colony formation. These results highlight the relevance of the proposed method for the identification of lncRNAs in specific biological contexts.

Entities:  

Keywords:  LINC00504; breast cancer; co-expression; lncRNA; luminal A

Mesh:

Substances:

Year:  2021        PMID: 33670895      PMCID: PMC7957645          DOI: 10.3390/ijms22052420

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  43 in total

1.  ERα Binding by Transcription Factors NFIB and YBX1 Enables FGFR2 Signaling to Modulate Estrogen Responsiveness in Breast Cancer.

Authors:  Thomas M Campbell; Mauro A A Castro; Kelin Gonçalves de Oliveira; Bruce A J Ponder; Kerstin B Meyer
Journal:  Cancer Res       Date:  2017-11-27       Impact factor: 12.701

2.  Quantitative gene profiling of long noncoding RNAs with targeted RNA sequencing.

Authors:  Michael B Clark; Tim R Mercer; Giovanni Bussotti; Tommaso Leonardi; Katelin R Haynes; Joanna Crawford; Marion E Brunck; Kim-Anh Lê Cao; Gethin P Thomas; Wendy Y Chen; Ryan J Taft; Lars K Nielsen; Anton J Enright; John S Mattick; Marcel E Dinger
Journal:  Nat Methods       Date:  2015-03-09       Impact factor: 28.547

3.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

4.  A noncoding RNA LINC00504 interacts with c-Myc to regulate tumor metabolism in colon cancer.

Authors:  Jinfeng Feng; Jun Ma; Shaoqun Liu; Jianfa Wang; Yi Chen
Journal:  J Cell Biochem       Date:  2019-04-18       Impact factor: 4.429

5.  FGFR2 risk SNPs confer breast cancer risk by augmenting oestrogen responsiveness.

Authors:  Thomas M Campbell; Mauro A A Castro; Ines de Santiago; Michael N C Fletcher; Silvia Halim; Radhika Prathalingam; Bruce A J Ponder; Kerstin B Meyer
Journal:  Carcinogenesis       Date:  2016-05-28       Impact factor: 4.944

Review 6.  Noncoding RNA:RNA Regulatory Networks in Cancer.

Authors:  Jia Jia Chan; Yvonne Tay
Journal:  Int J Mol Sci       Date:  2018-04-27       Impact factor: 5.923

7.  Translating the role of PARP inhibitors in triple-negative breast cancer.

Authors:  Michèle Beniey; Takrima Haque; Saima Hassan
Journal:  Oncoscience       Date:  2019-01-31

8.  An integrated encyclopedia of DNA elements in the human genome.

Authors: 
Journal:  Nature       Date:  2012-09-06       Impact factor: 49.962

9.  GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility.

Authors:  Vasiliki Theodorou; Rory Stark; Suraj Menon; Jason S Carroll
Journal:  Genome Res       Date:  2012-11-21       Impact factor: 9.043

10.  Molecular classification of breast cancer: A retrospective cohort study.

Authors:  Fatma Khinaifis Al-Thoubaity
Journal:  Ann Med Surg (Lond)       Date:  2019-12-06
View more
  1 in total

1.  GCEN: An Easy-to-Use Toolkit for Gene Co-Expression Network Analysis and lncRNAs Annotation.

Authors:  Wen Chen; Jing Li; Shulan Huang; Xiaodeng Li; Xuan Zhang; Xiang Hu; Shuanglin Xiang; Changning Liu
Journal:  Curr Issues Mol Biol       Date:  2022-03-25       Impact factor: 2.976

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.